Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A urological challenge: Voiding dysfunction in multiple sclerosis.
Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis.
Us Rrms Patient Preferences for Multiple Sclerosis Treatments: An Online Survey.
Back and forth in time: Directing age in iPSC-derived lineages.
Chronic stress regulates NG2(+) cell maturation and myelination in the prefrontal cortex through induction of death receptor 6.
The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective.
Increased activation of the epidermal growth factor receptor in transgenic mice overexpressing epigen causes peripheral neuropathy.
Acute-Phase Protein Hemopexin Is a Negative Regulator of Th17 Response and Experimental Autoimmune Encephalomyelitis Development.
Interleukin-7 Receptor Single Nucleotide Polymorphism rs6897932 (C/T) and the Susceptibility to Systemic Lupus Erythematosus.
Determination of Brain Volumes Using Quantitative MR Imaging in Patients with Multiple Sclerosis.
Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.
RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
The Impact of Methylprednisolone Pulses during Relapses of Multiple Sclerosis on the Kinetics of Anti-Interferon-Beta Antibodies.
Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
A disturbed processing of graviceptive pathways may be involved in the pathophysiology of balance disorders in patients with multiple sclerosis.
A Two Sample Distribution-Free Test for Functional Data with Application to a Diffusion Tensor Imaging Study of Multiple Sclerosis.
Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.
Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
Generic quality of life burden of multiple sclerosis as compared to other debilitating chronic conditions.
Aquaporin-4: A novel diagnostic biomarker for seronegative neuromyelitis optica.
The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination.
Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
Magnetic susceptibility contrast variations in multiple sclerosis lesions.
Chronic inflammatory demyelinating polyneuropathy in children: a report of four patients with variable relapsing courses.
Pages
« first
‹ previous
…
654
655
656
657
658
659
660
661
662
…
next ›
last »